The University of Chicago Header Logo

Connection

Jeremy Segal to Hydroxychloroquine

Back to Details
This is a "connection" page, showing publications Jeremy Segal has written about Hydroxychloroquine.
Jeremy Segal
Connection Strength
0.041
Hydroxychloroquine
  1. Autophagy Inhibition to Augment mTOR Inhibition: a Phase I/II Trial of Everolimus and Hydroxychloroquine in Patients with Previously Treated Renal Cell Carcinoma. Clin Cancer Res. 2019 04 01; 25(7):2080-2087.
    View in: PubMed
    Score: 0.041
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.